Tag Archives: Pancreatic Cancer

United States Was Ranked Seventh in Global Cancer Rates

Posted on April 2, 2011 by wngai

According to the data published by the American Institute for Cancer Research (AICR), the United States has the seventh highest cancer rate in the world, according to new data published by the American Institute for Cancer Research (AICR). Of the … Continue reading →

How to Prevent Common Cancers?

Posted on March 6, 2011 by wngai

The incidence and burden of cancer is huge. Nearly 12.7 million of people are diagnosed of cancer every day and 7.6 million die from cancer. The global cancer epidemic is set to continue rising, with the number of worldwide cancer … Continue reading →

Posted in Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Pancreatic Cancer, Renal Cancer | Tagged American Institute for Cancer Research, body mass index, Breast cancer, Cancer, colon cancer, Endometrial cancer, Esophageal Cancer, hepatitis B, human papilloma virus, kidney cancer, Pancreatic Cancer, Prevent+, stomach cancer, World Cancer Congress, World Cancer Research Fund | 1 Comment

Europe Approved Sutent for Rare Pancreatic Cancer

Posted on December 22, 2010 by wngai

The European Commission has recently approved Sutent (sunitinib) as a medicine for treating patients with pancreatic neuroendocrine tumors (NET). The drug is now indicated to treat unresectable metastatic, well-differentiated pancreatic NET in adults with disease progression. The approval was based … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged metastatic, Pancreatic Cancer, pancreatic neuroendocrine tumors, progression-free survival, sunitinib, Sutent | Comments Off

Anorexia and Cachexia – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment

Posted on November 27, 2010 by wngai

Anorexia in Cancer Cancer anorexia-cachexia syndrome (CACS) is an extremely common condition in cancer patients. It is estimated that 50% of cancer patients suffered from anorexia. The exact frequency of CACS varies according to the primary pathology (from 30% in … Continue reading →

Posted in Cancer, Gastric Cancer, Others, Pancreatic Cancer | Tagged AIDS, Anorexia, Bristol-Myers Squibb, Cachexia, Causes, chemotherapy, cyprohetadine, Diagnosis, dronabinol, Gastric Cancer, Lymphoma, malnutrition, Marinol, Megace, megestrol, Merck, Metastatic breast cancer, orexigenic, Oxandrin, oxandrolone, Pancreatic Cancer, Periactin, Prognosis, Symptoms, Treatment, Unimed, wasting | 2 Comments

Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors

Posted on July 25, 2010 by wngai

Pancreatic neuroendocrine tumors affect the hormone-producing tissues within the pancreas, and have an incidence rate, affecting only 2 to 4 people per million worldwide. The incidence, however, is rising, and has quadrupled in the past 30 years, according to data … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged Affinitor, anthracyclines, Everolimus, fluoropyrimidines, Neuroendocrine tumor, octreotide, Pancreatic Cancer, Sandostatin, streptozocin, sunitinib, Survival, Sutent, Zanosar | Comments Off

Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment

Posted on April 17, 2010 by wngai

Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading →

Posted in Pancreatic Cancer | Tagged Avastin, bevacizumab, capecitabine, Causes, Diagnosis, Eloxatin, erlotinib, gemcitabine, Gemzar, oxaliplatin, Pancreatic Cancer, Prevention, Prognosis, Survival, Tarceva, Treatment, Xeloda | 2 Comments